Non-contact Endoscopy at Covid-19 Outbreak

Sponsor
Changhai Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04320953
Collaborator
(none)
5
1
1
24
6.3

Study Details

Study Description

Brief Summary

The COVID-19 outbreak and spread throughout the world now constitutes a global public health emergency. Direct contact between doctors and patients in daily practice bears potential risk of Covid-19 infection, and telemedicine, or non-contact medicine, in this circumstance, offers an ideal solution. Remote controlling capsule endoscopy system for gastric examination was recently developed and applicated in clinical practice.

Condition or Disease Intervention/Treatment Phase
  • Device: Non-contact MCE system
N/A

Detailed Description

The novel non-contact magnetically-controlled capsule endoscopy (MCE) system (Ankon Technologies, China) adds a remote control workstation and a audio-visual exchange system to the original well-establish MCE system, which consists of a robotic magnetic arm, a workstation (now bypassed) and a capsule endoscope, and boasts a 90% sensitivity and 94% specificity for diagnosing gastric focal lesions. This feasibility study aims to evaluate the technical success, clinical success and adverse events of the first clinical application of non-contact MCE system.

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Non-contact Endoscopy at Covid-19 Outbreak
Actual Study Start Date :
Mar 16, 2020
Actual Primary Completion Date :
Mar 26, 2020
Actual Study Completion Date :
Apr 9, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Non-contact MCE examination

Study subject in this arm receives non-contact MCE examination.

Device: Non-contact MCE system
After an overnight fasting and drinking 1000 mL water and simethicone for gastric dilatation and preparation, the study subject positions himself (herself) on the examination bed in Room A, while the operating doctor sits in Room B at the remote control workstation instructing her to swallow the capsule via the audio-visual exchange system. After the capsule entering the stomach, the doctor manipulated the two joysticks on the remote control workstation, mobilizing the robotic magnetic arm, and simultaneously driving the precise movement and rotation of the capsule to perform the gastric examination.

Outcome Measures

Primary Outcome Measures

  1. Technical success [During the procedure]

    Maneuvarability of the remote control MCE system

Secondary Outcome Measures

  1. Clinical success [During the procedure]

    Complete observation of the mucosa (>90% of the mucosa observed) in gastric cardia, fundus, body, angulus, antrum and pylorus

  2. Adverse events [During and within 2 weeks after the procedure]

    Adverse events during and after the procedure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Signed the informed consents before joining this study
Exclusion Criteria:
  • Dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis, history of upper gastrointestinal surgery or abdominal surgery altering gastrointestinal anatomy

  • Refused abdominal surgery to take out the capsule in case of capsule retention

  • Implanted pacemaker, except the pacemaker is compatible with MRI

  • Other implanted electromedical devices or magnetic metal foreign bodies

  • Pregnancy or suspected pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Changhai Hospital Shanghai China 200433

Sponsors and Collaborators

  • Changhai Hospital

Investigators

  • Principal Investigator: Zhuan Liao, MD, Changhai Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Zhuan Liao, Principal Investigator, Changhai Hospital
ClinicalTrials.gov Identifier:
NCT04320953
Other Study ID Numbers:
  • ncMCE1
First Posted:
Mar 25, 2020
Last Update Posted:
Apr 17, 2020
Last Verified:
Apr 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 17, 2020